Publications by authors named "Joseph Antin"

Claim this Profile
A
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study.
Oren Pasvolsky, Shai Shimony, Rima M Saliba, Curtis Marcoux, Celina Ledesma, Joseph H Antin

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AML.
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Anna Bosch-Vilaseca, Kevin M Panaro, Joseph H Antin

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS.
Nurefsan E Sariipek, Ksenia R Safina, Wesley S Lu, Shuqiang Li, J Thomas Janes, Joseph H Antin

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.
H Moses Murdock, Haesook T Kim, Katie Maurer, Amar H Kelkar, Roman M Shapiro, Joseph H Antin

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced incidence of relapse and graft--host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation.
Haesook T Kim, Robert J Soiffer, Corey Cutler, John Koreth, Sarah Nikiforow, Joseph H Antin

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Myelofibrosis.
Haesook T Kim, Deborah J Liney, Kristen Rizza, Corey S Cutler, John Koreth, Joseph H Antin

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell Transplantation.
Jessica S Little, Kyle M Hebert, Donna S Neuberg, Sarah Nikiforow, Mahasweta Gooptu, Joseph H Antin

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
Mark C Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K Waller, Joseph H Antin

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, Rizwan Romee, Navneet S Majhail, Joseph H Antin

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial.
Gregory A Abel, Haesook T Kim, Ira Zackon, Edwin T Alyea, Alexandra S Bailey, Joseph H Antin

JAMA Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy.
Raheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, Michael A Pulsipher, Nelli Bejanyan, Joseph H Antin

Transplant Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.
Mary Eapen, Joseph H Antin, Jakub Tolar, Sally Arai, Mitchell E Horwitz

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival.
Roman M Shapiro, Haesook T Kim, Remy Dulery, Deborah Liney, Heather M Garrity, Joseph H Antin

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202.
Laura F Newell, Najla El Jurdi, Brian C Betts, Corey Cutler, Joseph H Antin

Blood Vessel Thromb Hemost· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis.
Haesook T Kim, Vincent T Ho, Sarah Nikiforow, Corey Cutler, John Koreth, Joseph H Antin

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial.
Hermioni L Amonoo, Elizabeth Daskalakis, Emma D Wolfe, Michelle Guo, Christopher M Celano, Joseph H Antin

J Natl Compr Canc Netw· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy.
Katie Maurer, Joseph H Antin

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft.
Jessica S Little, Rémy Duléry, Roman M Shapiro, Muneerah M Aleissa, Susan E Prockop, Joseph H Antin

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Joseph H Antin

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children Are Not Just Small Adults.
Joseph H Antin

Transplant Cell Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.
Katie Maurer, Vincent T Ho, Eno Inyang, Corey Cutler, John Koreth, Joseph H Antin

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, Indira Guleria, Corey S Cutler, Joseph H Antin

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Juliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, Alisha Yi, Meghan E Sise, Joseph H Antin

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term health outcomes of allogeneic hematopoietic stem cell transplantation.
Amar H Kelkar, Joseph H Antin, Roman M Shapiro

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease.
Neha Gupta, Cesar A Virgen, Amrita Goyal, Andrew A Lane, Joseph H Antin

JAAD Case Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis